Evidence map›Paper›PMID 40034395›Full record

ArticleFrontiers in cellular and infection microbiology2025

Serology reveals comparable patterns in the transmission intensities of

Inke Nadia Diniyanti Lubis, Irbah Rea Alvieda Nainggolan, Meliani Meliani, Beby Syofiani Hasibuan, Kumuthamalar Sangaran, Luqman Samsudin, Sriwipa Chuangchaiya, Paul Cliff Simon Divis, Ranti Permatasari, Zulkarnain Md Idris

Abstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Serological evidence of continued exposure toFrontiers in microbiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Inke Nadia Diniyanti LubisFaculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia.
Irbah Rea Alvieda NainggolanFaculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia.
Meliani MelianiFaculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia.
Beby Syofiani HasibuanFaculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia.
Kumuthamalar SangaranDepartment of Parasitology and Medical Entomology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
Luqman SamsudinVector-Borne Disease Unit, Lipis District Health Office, Kuala Lipis, Pahang, Malaysia.
Sriwipa ChuangchaiyaDepartment of Community Health, Faculty of Public Health, Kasetsart University, Sakon Nakhon, Thailand.
Paul Cliff Simon DivisMalaria Research Centre, Faculty of Medicine and Health Sciences, Universiti Malaysia Sarawak, Kota Samarahan, Sarawak, Malaysia.
Ranti PermatasariFaculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia.
Zulkarnain Md IdrisDepartment of Parasitology and Medical Entomology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The incidence of malaria in Indonesia has declined significantly over the last few decades. Thus, a demand for more sensitive techniques to describe low levels of transmission in the country is important. This study was conducted to evaluate antibody response to Methods: A cross-sectional survey was conducted in Langkat district, North Sumatera Province, in June 2019. Basic demographic data and filter paper blood spots were collected from 339 participants. Antibody responses to two Results: The overall malaria seroprevalence was 10.6% for PfAMA-1, 13% for PfMSP-1 Conclusion: The analysis of community-based serological data helps describe the similar levels of

Indexed as

Antibodies, ProtozoanMalaria, FalciparumMalaria, VivaxPlasmodium falciparumPlasmodium vivaxAdolescentAdultAgedAntigens, ProtozoanChildChild, PreschoolCross-Sectional StudiesEnzyme-Linked Immunosorbent AssayFemaleHumansIndonesiaAntibodies, ProtozoanAntigens, ProtozoanProtozoan ProteinsIndonesiamalariaP. falciparumP. vivaxserologytransmission

Identifiers

PMID40034395
PMCPMC11873072

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.